PROFITELLIGENCE/Guest access
!
Financial disclaimer

Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.

Legal agreement

By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.

i
Guest mode

You're browsing as a guest. Some features like watchlists and alerts require a free account.

--:--:--
Guest mode— viewing ZTS. Sign up free to access all symbols.Sign up
ZTS logo

ZTS

Zoetis Inc. Class A Common Stock

HealthcareDrug Manufacturers - Specialty & Generic

Price performance

Sep 18, 2026
$71.4
$1.62-2.22%
1M
-6.89%
3M
-9.29%
YTD
-43.30%
vs SPY
-4.71%
30d range
71–79
Volatility
30.15%
Signals
Price chart

Company activity

36 events
Company activity
TimeTickerTypeEventQtyPriceValue
08/06ZTS8-KZoetis Appoints New Executive Vice President, CFO, and COO
08/06ZTS8-KZoetis Reports Second Quarter 2026 Results and Updates Full Year Guidance
05/21ZTS8-KZoetis Inc. Board Member Louise M. Parent Retires Ahead of Annual Meeting
05/20ZTS8-KZoetis Declares Third Quarter 2026 Dividend
05/07ZTS8-KZoetis Reports Q1 2026 Results and Updates Full Year Guidance
02/12ZTS8-KZoetis Reports 2025 Financial Results and Provides 2026 Guidance
02/05ZTS8-KZoetis Declares Second Quarter 2026 Dividend
12/18/25ZTS8-KZoetis Announces $2.0 Billion Convertible Senior Notes Offering
12/11/25ZTS8-KZoetis Declares First Quarter 2026 Dividend and Announces 6% Increase
12/02/25ZTS8-KZoetis Inc. to Host Innovation Webcast on December 2, 2025
11/04/25ZTS8-KZoetis Reports Q3 2025 Financial Results and Updates Full-Year Guidance
10/28/25ZTS8-KZoetis Appoints Stephanie Tilenius to its Board of Directors
10/09/25ZTS8-KZoetis Declares Fourth Quarter 2025 Dividend
08/27/25ZTS8-KZoetis Inc. Enters into New Revolving Credit Agreement and Terminates Prior Agreement
08/18/25ZTS8-KZoetis Inc. Announces Issuance of Senior Notes
08/05/25ZTS8-KZoetis Reports Strong Second Quarter 2025 Results and Raises Full Year Guidance
05/22/25ZTS8-KZoetis Announces Board Changes and Shareholder Proposal Results
05/21/25ZTS8-KZoetis Declares Third Quarter 2025 Dividend
05/06/25ZTS8-KZoetis Reports Q1 2025 Results and Updates Full Year 2025 Guidance
02/13/25ZTS8-KZoetis Reports Q4 2024 Results and Provides 2025 Guidance
02/06/25ZTS8-KZoetis Declares $0.500 Dividend for Q2 2025
01/13/25ZTS8-KZoetis Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
12/12/24ZTS8-KZoetis Announces 16% Dividend Increase for Q1 2025
11/12/24ZTS8-KZoetis Announces Key Leadership Changes
11/04/24ZTS8-KZoetis Reports Strong Q3 2024 Financial Results and Raises Full-Year Guidance
10/10/24ZTS8-KZoetis Inc. Declares Fourth Quarter 2024 Dividend
08/06/24ZTS8-KZoetis Raises Full Year 2024 Guidance Following Strong Second Quarter
08/01/24ZTS8-KZoetis Inc. Announces $6 Billion Share Repurchase Program
05/24/24ZTS8-KZoetis Announces Heidi C. Chen's Transition to Consultant Role
05/23/24ZTS8-KZoetis Inc. Announces Board Member Departure and Shareholder Votes on Governance Proposals
05/22/24ZTS8-KZoetis Declares Third Quarter 2024 Dividend
05/02/24ZTS8-KZoetis Reports Strong Q1 2024 Results and Updates Full-Year Guidance
04/16/24ZTS8-KZoetis Inc. Announces Resignation of Executive Vice President and General Counsel Heidi C. Chen
04/01/24ZTS8-KZoetis Appoints Gavin D.K. Hattersley to its Board of Directors
02/13/24ZTS8-KZoetis Reports Strong Q4 2023 Results and Provides 2024 Guidance
02/06/24ZTS8-KZoetis Announces Second Quarter 2024 Dividend

ZTS filing record

Zoetis Inc. Class A Common Stock (ZTS): 36 8-K filings summarized, the most recent on Aug 6, 2026.

What the 8-K filings said

  1. Aug 6, 2026 · high impact

    Zoetis Inc. announced on August 6, 2026, the appointment of James Saccaro as Executive Vice President, Chief Financial Officer, and Chief Operating Officer, effective August 17, 2026. Mr. Saccaro will lead Zoetis' global finance function and oversee Global Manufacturing and Supply. Wetteny Joseph, the current CFO…

    Zoetis Appoints New Executive Vice President, CFO, and COO
  2. Aug 6, 2026 · high impact

    Zoetis Inc. reported flat revenue of $2.5 billion and a slight decrease in net income for the second quarter of 2026. The company also revised its full-year 2026 guidance, lowering both revenue and adjusted net income expectations. The U.S. segment saw a decline in revenue, while the International segment experienced…

    Zoetis Reports Second Quarter 2026 Results and Updates Full Year Guidance
  3. May 21, 2026 · medium impact

    Zoetis Inc. announced that Ms. Louise M. Parent retired from the Board of Directors on May 20, 2026, prior to the Company's 2026 Annual Meeting of Shareholders in accordance with the Company's director retirement policy. At the Annual Meeting, shareholders elected twelve directors, approved the compensation program…

    Zoetis Inc. Board Member Louise M. Parent Retires Ahead of Annual Meeting
  4. May 20, 2026 · medium impact

    Zoetis Inc. has declared a dividend of $0.53 per share for the third quarter of 2026, to be paid on September 1, 2026, to shareholders of record as of July 20, 2026. This dividend reflects the company's commitment to returning value to its shareholders and is a key financial event for the company.

    Zoetis Declares Third Quarter 2026 Dividend
  5. May 7, 2026 · high impact

    Zoetis Inc. reported a 3% increase in revenue to $2.3 billion for Q1 2026, with net income of $601 million and adjusted net income of $646 million. The company revised its full-year 2026 revenue guidance to $9.680 - $9.960 billion with organic operational revenue growth of 2% to 5%. Adjusted net income guidance for…

    Zoetis Reports Q1 2026 Results and Updates Full Year Guidance

SEC filings in the last five years

  • 60 Form 8-K
  • 13 Form 10-Q
  • 5 Form 10-K